ArticleJournal for immunotherapy of cancer2025

Priming the tumor microenvironment with pembrolizumab and radiotherapy for durable cures in high-risk localized undifferentiated pleomorphic sarcoma and pleomorphic/dedifferentiated liposarcoma.

Aastha Sobti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.